VIETRI, LUCIA
 Distribuzione geografica
Continente #
EU - Europa 1.186
NA - Nord America 967
AS - Asia 148
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.307
Nazione #
US - Stati Uniti d'America 958
IT - Italia 320
GB - Regno Unito 260
IE - Irlanda 248
SE - Svezia 105
CN - Cina 75
DE - Germania 53
FR - Francia 48
UA - Ucraina 39
FI - Finlandia 34
RU - Federazione Russa 31
SG - Singapore 24
ES - Italia 16
IN - India 16
CZ - Repubblica Ceca 15
CA - Canada 8
KR - Corea 8
BE - Belgio 5
IR - Iran 5
TR - Turchia 5
JP - Giappone 4
VN - Vietnam 4
AU - Australia 3
BG - Bulgaria 3
HK - Hong Kong 3
LT - Lituania 2
NL - Olanda 2
PT - Portogallo 2
AZ - Azerbaigian 1
EG - Egitto 1
EU - Europa 1
JO - Giordania 1
KG - Kirghizistan 1
LV - Lettonia 1
PA - Panama 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 2.307
Città #
Southend 254
Dublin 244
Fairfield 147
Chandler 130
Ashburn 80
Wilmington 55
Woodbridge 55
Lastra a Signa 54
Seattle 54
Houston 49
Siena 42
Cambridge 40
Princeton 34
Helsinki 32
Jacksonville 31
New York 27
Beijing 25
Ann Arbor 22
Milan 21
Gavirate 18
San Mateo 17
Fremont 16
Málaga 16
Dearborn 15
Florence 15
Shanghai 15
Singapore 15
Brno 13
Rome 12
Boardman 10
Comun Nuovo 10
Munich 9
Moscow 8
Chicago 7
San Diego 7
Anagni 6
Padova 6
Agliana 5
Brescia 5
Brussels 5
Yeongdeungpo-gu 5
Cagliari 4
Dallas 4
Dong Ket 4
Fiesole 4
Genoa 4
Izmir 4
Livorno 4
Paris 4
Toronto 4
Washington 4
Wuhan 4
Athis-mons 3
Bangalore 3
Guagnano 3
Hanover 3
Hefei 3
Nanchang 3
Nanjing 3
Redwood City 3
Verona 3
Winnipeg 3
Wŏnju 3
Zhengzhou 3
Bergamo 2
Bonndorf 2
Carbonara di Nola 2
Castel Madama 2
Cincinnati 2
Clifton 2
Jamaica Plain 2
Jiaxing 2
Jinan 2
Kaunas 2
Kilburn 2
Kyiv 2
Lappeenranta 2
Leawood 2
London 2
Macerata 2
Olomouc 2
Parma 2
Pedrengo 2
Pimonte 2
Sydney 2
Uppsala 2
Varna 2
Vicenza 2
Albairate 1
Almere Stad 1
Amman 1
Amsterdam 1
Andover 1
Arezzo 1
Baku 1
Belgrade 1
Bishkek 1
Bologna 1
Cairo 1
Campoformido 1
Totale 1.771
Nome #
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 172
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 159
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 152
Serum amyloid A in patients with idiopathic pulmonary fibrosis 133
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 132
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 124
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 119
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 113
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 112
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 111
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 110
Serum amyloid A: A potential biomarker of lung disorders 108
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 107
Serum amyloid A: a new biomarker in Idiopathic Pulmonary Fibrosis 105
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 100
Effects of rituximab therapy on B cell differentiation and depletion 99
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 95
An explainable model of host genetic interactions linked to COVID-19 severity 82
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 71
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis 65
Serum Amyloid A in lung transplantation 61
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 17
Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis 12
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 11
Author reply 10
Correction to: BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases (Clinical and Experimental Medicine, (2020), 20, 2, (207-216), 10.1007/s10238-020-00608-5) 9
Siero Amiloide A: nuovo potenziale biomarcatore di Fibrosi Polmonare Idiopatica. 7
Chilotorace maligno: patogenesi e valore prognostico. 5
Role of EBUS-TBNA in interstitial lung diseases: a case report of lymphangitis carcinomatosa. 5
The thin line between sarcoidosis and cancer: can we consider PET as an oncologic screening tool in radiologically stable and asymptomatic sarcoidosis? 5
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 5
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 2
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 2
Eterogeneità clinica e radiologica della sarcoidosi: case report di sarcoidosi sistemica con coinvolgimento osseo con aspetti di malignità. 2
A case report on expanding horizon of endobronchial ultrasound through esophagus 2
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital. 2
Totale 2.426
Categoria #
all - tutte 8.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.843


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 0 9 5 28 23 30 27 52 56 37 20 29
2020/2021481 21 38 15 64 44 66 55 61 36 33 25 23
2021/2022325 20 52 35 26 8 5 14 11 12 47 33 62
2022/2023466 25 52 35 40 27 79 31 57 53 30 30 7
2023/2024589 21 22 63 10 17 142 152 28 4 14 18 98
2024/2025153 114 39 0 0 0 0 0 0 0 0 0 0
Totale 2.426